Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
24/12/2009 | 14:00 | Business Wire | NovaDel Announces Listing on OTC Bulletin Board | AMEX:NVD | Novadel Pharma, |
15/12/2009 | 15:00 | Business Wire | NovaDel Receives Issue Notification for New U.S. Patent Covering its Oral Spray Drug Delivery Technology | AMEX:NVD | Novadel Pharma, |
14/12/2009 | 16:20 | Edgar (US Regulatory) | -National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25) | AMEX:NVD | Novadel Pharma, |
10/12/2009 | 15:26 | Edgar (US Regulatory) | Amended Current report filing (8-K/A) | AMEX:NVD | Novadel Pharma, |
03/12/2009 | 22:08 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:NVD | Novadel Pharma, |
03/12/2009 | 22:05 | Business Wire | NovaDel Announces Voluntary Delisting from NYSE Amex LLC and Pending Transfer to the Over-the-Counter Bulletin Board | AMEX:NVD | Novadel Pharma, |
01/12/2009 | 21:47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:NVD | Novadel Pharma, |
16/11/2009 | 22:27 | Business Wire | NovaDel Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2009 | AMEX:NVD | Novadel Pharma, |
16/11/2009 | 18:59 | Edgar (US Regulatory) | Quarterly Report (10-Q) | AMEX:NVD | Novadel Pharma, |
16/11/2009 | 15:00 | Business Wire | NovaDel Signs Exclusive License & Distribution Agreement with Hi-Tech Pharmacal Co., Inc.’s Subsidiary to Commercialize & M... | AMEX:NVD | Novadel Pharma, |
05/11/2009 | 15:03 | Business Wire | NovaDel Receives Notice of Allowance for New U.S. Patent Covering its Oral Spray Drug Delivery Technology | AMEX:NVD | Novadel Pharma, |
27/10/2009 | 21:30 | Business Wire | NovaDel Licenses its NitroMist® Lingual Spray to Mist | AMEX:NVD | Novadel Pharma, |
21/10/2009 | 16:51 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | AMEX:NVD | Novadel Pharma, |
16/10/2009 | 15:16 | Business Wire | NovaDel Holds Annual Meeting | AMEX:NVD | Novadel Pharma, |
02/09/2009 | 18:29 | Business Wire | NovaDel Article Published in Headache: The Journal of Head and Face Pain | AMEX:NVD | Novadel Pharma, |
24/08/2009 | 14:15 | Business Wire | NovaDel Receives Milestone Payment from Velcera, Inc. | AMEX:NVD | Novadel Pharma, |
12/08/2009 | 15:30 | Business Wire | NovaDel Reports Financial Results for Second Quarter and Six Months ended June 30, 2009 | AMEX:NVD | Novadel Pharma, |
20/07/2009 | 15:00 | Business Wire | NovaDel Receives Approval to Issue up to 12.0 Million Shares over the Next 12 Months | AMEX:NVD | Novadel Pharma, |
17/07/2009 | 12:27 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | AMEX:NVD | Novadel Pharma, |
09/07/2009 | 17:13 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:NVD | Novadel Pharma, |
29/06/2009 | 16:13 | Business Wire | NovaDel Receives Commitment of Investment Fund to Purchase up to 13.0 Million Shares over the Next 12 Months | AMEX:NVD | Novadel Pharma, |
24/06/2009 | 12:00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | AMEX:NVD | Novadel Pharma, |
15/06/2009 | 23:03 | Edgar (US Regulatory) | Securities Registration Statement (simplified form) (S-3/A) | AMEX:NVD | Novadel Pharma, |
22/05/2009 | 16:25 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | AMEX:NVD | Novadel Pharma, |
15/05/2009 | 21:08 | Business Wire | NovaDel Reports Financial Results for First Quarter 2009 | AMEX:NVD | Novadel Pharma, |
12/05/2009 | 23:04 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(3) (424B3) | AMEX:NVD | Novadel Pharma, |
07/05/2009 | 22:05 | Business Wire | NYSE AMEX LLC Determines NovaDel Made Reasonable Demonstration of Its Ability to Regain Compliance | AMEX:NVD | Novadel Pharma, |
29/04/2009 | 23:02 | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | AMEX:NVD | Novadel Pharma, |
30/03/2009 | 22:21 | Business Wire | NovaDel Reports Financial Results for the Year Ended December 31, 2008 | AMEX:NVD | Novadel Pharma, |
30/03/2009 | 21:02 | Edgar (US Regulatory) | Annual Report (10-K) | AMEX:NVD | Novadel Pharma, |